IP Verse

Revance Therapeutics, Inc. vs Medy-Tox, Inc.

The detailed information for PTAB case with proceeding number IPR2021-01204 filed by Revance Therapeutics, Inc. against Medy-Tox, Inc. on Jul 1, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2021-01204
Filing Date
Jul 1, 2021
Petitioner
Revance Therapeutics, Inc.
Respondent
Medy-Tox, Inc.
Status
Institution Denied
Respondent Application Number
14567289
Respondent Tech Center
1600
Respondent Patent Number
9480731
Institution Decision Date
Jan 19, 2022
Termination Date
Jan 19, 2022

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Denying Petitioner Request on Rehearing of Decision Denying Institution 37 C.F.R. ยง 42.71(d)

Aug 4, 2022PAPERBOARD

Petitioner's Request for Rehearing

Feb 18, 2022PAPERPETITIONER

Institution Decision: Deny

Jan 19, 2022PAPERBOARD

Exhibit 3001

Jan 19, 2022EXHIBITBOARD

Patent Owner's Sur-Reply to Petitioner's Reply to Patent Owner's Preliminary Response

Dec 6, 2021PAPERPATENT OWNER

Petitioner's Reply to POPR

Nov 29, 2021PAPERPETITIONER

Petitioner's Updated Mandatory Notices

Nov 18, 2021PAPERPETITIONER

Broide et al., Toxicon. 2013 May;71:18-24.

Oct 26, 2021EXHIBITPATENT OWNER

Kwak et al., Dermatologic Surgery. 2020 Dec;46:e132-e138.

Oct 26, 2021EXHIBITPATENT OWNER

Marur et al., Clinics in Dermatology. 2014 Jan;32:14-23.

Oct 26, 2021EXHIBITPATENT OWNER

Monroy et al., Journal of Visualized Experiments. 2015 Jul;101:e52802. 11 pages.

Oct 26, 2021EXHIBITPATENT OWNER

Moore et al., Frontiers in Zoology. 2017 Jul;14:32. 12 pages.

Oct 26, 2021EXHIBITPATENT OWNER

Rupp et al., Toxins. 2020 Jun;12:393. 15 pages.

Oct 26, 2021EXHIBITPATENT OWNER

Sattler et al., Dermatologic Surgery. 2010 Dec;36:2146-54.

Oct 26, 2021EXHIBITPATENT OWNER

McCluskey et al., Continuing Education in Anaesthesia, Critical Care and Pain. 2007 Dec;7(6):208-12.

Oct 26, 2021EXHIBITPATENT OWNER

Glogau et al., Journal of Drugs in Dermatology: JDD. 2012 Jan;11(1):38-45.

Oct 26, 2021EXHIBITPATENT OWNER

Schiaffino et al., Physiological reviews. 2011 Oct;91:1447-531.

Oct 26, 2021EXHIBITPATENT OWNER

Revance Press Release Details. June 13, 2016.

Oct 26, 2021EXHIBITPATENT OWNER

Zhu et al., Chemical biology & drug design. 2009 Feb;73:209-15.

Oct 26, 2021EXHIBITPATENT OWNER

Duquemin et al., Journal of pharmacy and pharmacology. 1985 Oct;37:698-702.

Oct 26, 2021EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

Oct 26, 2021PAPERPATENT OWNER

Patent Owner's First Updated Mandatory Notices

Sep 15, 2021PAPERPATENT OWNER

Patent Owner's Mandatory Notices

Aug 30, 2021PAPERPATENT OWNER

Patent Owner's Power of Attorney

Aug 30, 2021PAPERPATENT OWNER

Notice of Accord Filing Date

Jul 26, 2021PAPERBOARD

USPN 9,480,731 B2

Jul 1, 2021EXHIBITPETITIONER

Andreas Rummel CV

Jul 1, 2021EXHIBITPETITIONER

U.S. Pat Appl. Publ. 2010/0168023 A1

Jul 1, 2021EXHIBITPETITIONER

U.S. Pat Appl. Publ, 2010/0291136 A1 - Jung I

Jul 1, 2021EXHIBITPETITIONER

Carruthers 2013

Jul 1, 2021EXHIBITPETITIONER

BOTOX PDR 2003

Jul 1, 2021EXHIBITPETITIONER

Xeomin prescribing label 2011

Jul 1, 2021EXHIBITPETITIONER

Dysport prescribing label 2009

Jul 1, 2021EXHIBITPETITIONER

Wu 2012

Jul 1, 2021EXHIBITPETITIONER

WO 2010/090677 A1

Jul 1, 2021EXHIBITPETITIONER

U.S. Pat Appl. Publ. 2008/0069841 A1

Jul 1, 2021EXHIBITPETITIONER

U.S. Pat Appl. Publ. 2011/0092682 A1

Jul 1, 2021EXHIBITPETITIONER

USPN 7,829,525 B2

Jul 1, 2021EXHIBITPETITIONER

USPN 9,480,731 File History

Jul 1, 2021EXHIBITPETITIONER

U.S. Pat Appl. Publ. 2003/0224020 A1

Jul 1, 2021EXHIBITPETITIONER

Korean Pat Publ. 10-2012-0112248 - Jung II

Jul 1, 2021EXHIBITPETITIONER

USPN 8,137,677 B2

Jul 1, 2021EXHIBITPETITIONER

Nowell Solish, MD FRCP CV

Jul 1, 2021EXHIBITPETITIONER

Botox prescribing label 2013

Jul 1, 2021EXHIBITPETITIONER

Brin 2014

Jul 1, 2021EXHIBITPETITIONER

Carruthers 2005

Jul 1, 2021EXHIBITPETITIONER

U.S. Pat Appl. Publ. 2010/0330123 A1

Jul 1, 2021EXHIBITPETITIONER

U.S. Pat Appl. Publ. 2006/0018931 A1

Jul 1, 2021EXHIBITPETITIONER

Winter 2010

Jul 1, 2021EXHIBITPETITIONER

Montecucco 2005

Jul 1, 2021EXHIBITPETITIONER

McLellan 1996

Jul 1, 2021EXHIBITPETITIONER

Sesardic 2003

Jul 1, 2021EXHIBITPETITIONER

Aoki 2001

Jul 1, 2021EXHIBITPETITIONER

Pearce 1995

Jul 1, 2021EXHIBITPETITIONER

Sesardic 1996

Jul 1, 2021EXHIBITPETITIONER

Aoki 1999

Jul 1, 2021EXHIBITPETITIONER

Dr. Ashwani Singh Dec

Jul 1, 2021EXHIBITPETITIONER

USPN 10,143,728 B2

Jul 1, 2021EXHIBITPETITIONER

Toth 2009

Jul 1, 2021EXHIBITPETITIONER

Wenzel 2004

Jul 1, 2021EXHIBITPETITIONER

De Boulle 2010

Jul 1, 2021EXHIBITPETITIONER

Prager 2013

Jul 1, 2021EXHIBITPETITIONER

Fagien and Respaldo 2007

Jul 1, 2021EXHIBITPETITIONER

Kim 2011

Jul 1, 2021EXHIBITPETITIONER

Kutschenko 2011

Jul 1, 2021EXHIBITPETITIONER

Lee 2013

Jul 1, 2021EXHIBITPETITIONER

Ziegler and Seelig 2004

Jul 1, 2021EXHIBITPETITIONER

Sylvia D. Hall-Ellis, Ph.D. Declaration

Jul 1, 2021EXHIBITPETITIONER

Mosby's Dictionary

Jul 1, 2021EXHIBITPETITIONER

U.S. Pat Appl. Publ. 2008/0050352 A1

Jul 1, 2021EXHIBITPETITIONER

Paper Np. 14 - Institution Decision

Jul 1, 2021EXHIBITPETITIONER

Paper No. 11 - POPR

Jul 1, 2021EXHIBITPETITIONER

Revance Therapeutics, Inc. POA

Jul 1, 2021PAPERPETITIONER

Andreas Rummel, Ph.D. Declaration

Jul 1, 2021EXHIBITPETITIONER

Nowell Jay Solish, M.D., FRCP Declaration

Jul 1, 2021EXHIBITPETITIONER

Petition for IPR

Jul 1, 2021PAPERPETITIONER